beta

AMGN

Amgen, Inc.

Amgn

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Market Cap: 139 Billion

Primary Exchange: NASDAQ

Website: http://www.amgen.com

Shares Outstanding: 594 Million

Float: 593 Million

Dividend: 5.67 (0.02%)

Beta: 0.778416641051818

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Animal testing

Longest drawdown: 397 trading days

From: 2015-07-31 To: 2017-02-28

Lowest Point:

FDA Approves Amgen And Allergan's KANJINTI(TM) (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab)

via: PR Newswire at 2019-06-13 15:13:00:000

THOUSAND OAKS, Calif. , June 13, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved KANJINTI (trastuzumab-anns) for all approved indications of the reference product, Herceptin … read more...

Amgen Inc. (AMGN) Management Presents at Goldman Sachs 40th Annual Global Healthcare Conference (Transcript)

via: SeekingAlpha at 2019-06-12 14:29:07:000

Amgen Inc. (NASDAQ:AMGN) Goldman Sachs 40th Annual Global Healthcare Conference June 12, 2019 2:20 PM ET Company Participants David Reese - Executive Vice President of R&D Conference Call Participants Terence Flynn - Goldman Sachs Presentation Terence Flynn Okay,… read more...

Amgen Inc. (AMGN) Management Presents at Goldman Sachs 40th Annual Global Healthcare Conference (Transcript)

via: SeekingAlpha at 2019-06-12 14:29:07:000

Amgen Inc. (NASDAQ:AMGN) Goldman Sachs 40th Annual Global Healthcare Conference June 12, 2019 2:20 PM ET Company Participants David Reese - Executive Vice President of R&D Conference Call Participants Terence Flynn - Goldman Sachs Presentation Terence Flynn Okay,… read more...

Amgen Publishes Offer Document With Respect To The Recommended Public Cash Offer To The Shareholders Of Nuevolution

via: PR Newswire at 2019-06-12 05:17:00:000

THOUSAND OAKS, California , June 12, 2019 /PRNewswire/ -- The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, Australia , Canada , Hong Kong , Japa… read more...

Amgen Publishes Offer Document With Respect To The Recommended Public Cash Offer To The Shareholders Of Nuevolution

via: PR Newswire at 2019-06-12 05:17:00:000

THOUSAND OAKS, California , June 12, 2019 /PRNewswire/ -- The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, Australia , Canada , Hong Kong , Japa… read more...

How To Find Undervalued Stocks In The Healthcare Sector

via: SeekingAlpha at 2019-06-10 12:10:41:000

The healthcare sector is underperforming the market by a wide margin on a year to date basis. The Healthcare Select Sector ETF ( XLV ) has gained 5.2%, while the SPDR S&P 500 ( SPY ) is up by almost three times that, with a cumulative gain of 15.1% in the same period. Data by YCharts … read more...

How To Find Undervalued Stocks In The Healthcare Sector

via: SeekingAlpha at 2019-06-10 12:10:41:000

The healthcare sector is underperforming the market by a wide margin on a year to date basis. The Healthcare Select Sector ETF ( XLV ) has gained 5.2%, while the SPDR S&P 500 ( SPY ) is up by almost three times that, with a cumulative gain of 15.1% in the same period. Data by YCharts … read more...

Monthly Review Of DivGro: May 2019

via: SeekingAlpha at 2019-06-09 12:11:30:000

Welcome to another monthly review of DivGro, my portfolio of dividend growth stocks. I present details of any buys or sells and provide a summary of dividends collected. Additionally, I look at how the month's activities have impacted DivGro's projected annual dividend income ((PADI)). In Ma… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
2019-11-14 2019-12-06 2019-11-15 2019-10-22 1.45 Cash
2019-08-14 2019-09-06 2019-08-15 2019-08-02 1.45 No Change QoQ
2019-05-16 2019-06-07 2019-05-17 2019-03-07 1.45 No Change QoQ
2019-02-14 2019-03-08 2019-02-15 2018-12-07 1.45 Increase
2018-11-15 2018-12-07 2018-11-16 2018-10-23 1.32 No Change QoQ
2018-08-16 2018-09-07 2018-08-17 2018-07-31 1.32 No Change QoQ
2018-05-16 2018-06-08 2018-05-17 2018-03-07 1.32 No Change QoQ
2018-02-14 2018-03-08 2018-02-15 2017-12-12 1.32 Increase
2017-11-16 2017-12-08 2017-11-17 2017-10-24 1.15 No Change QoQ
2017-08-15 2017-09-08 2017-08-17 2017-07-28 1.15 No Change QoQ
2017-05-15 2017-06-08 2017-05-17 2017-03-07 1.15 No Change QoQ
2017-02-13 2017-03-08 2017-02-15 2016-12-20 1.15 Increase
2016-11-14 2016-12-08 2016-11-16 2016-10-14 1.0 No Change QoQ
2016-08-15 2016-09-08 2016-08-17 2016-07-22 1.0 No Change QoQ
2016-05-13 2016-06-08 2016-05-17 2016-03-02 1.0 No Change QoQ
2016-02-11 2016-03-08 2016-02-16 2015-12-15 1.0 Increase
2015-11-12 2015-12-07 2015-11-16 2015-10-14 0.79 No Change QoQ
2015-08-13 2015-09-08 2015-08-17 2015-07-28 0.79 No Change QoQ
2015-05-12 2015-06-05 2015-05-14 2015-03-04 0.79 No Change QoQ
2015-02-10 2015-03-06 2015-02-12 2014-12-17 0.79 Increase
2014-11-11 2014-12-05 2014-11-13 2014-10-17 0.61 No Change QoQ
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud